Uplight Adds New Investors Schneider Electric and Huck Capital-Led Investment Group in Deal Valued at $1.5 Billion, with Growth Capital to Accelerate the Clean Energy Ecosystem
3.3.2021 08:01:00 EET | Business Wire | Press release
Uplight, the technology partner of energy providers transitioning to the clean energy ecosystem, announced today that it has agreed to a new investment from a consortium of investors, co-led by Schneider Electric (EURONEXT:SU), the global leader in sustainable energy solutions; AES (NYSE:AES), a global company accelerating the future of sustainable energy; and a group of private equity investors led by Huck Capital that includes Coatue and Inclusive Capital Partners Spring Fund II. Uplight is valued at $1.5 billion in the transaction, which includes the investment of new equity to support significant organic and inorganic growth and adds world-class strategic and financial partners as the energy industry surges forward into transformation. Prior Uplight majority investor Rubicon Technology Partners, who along with AES led the formation of Uplight through the merger of six companies, will also remain a minority investor.
“The grid is experiencing its biggest change in 100 years as it decarbonizes in front of our eyes. The boom in clean hardware — electric vehicles, renewables, batteries, and connected devices — is rapidly changing energy demand and creating new complexity. Uplight is creating the software operating system that connects the dots between customer choice and control and grid resilience and affordability in this transformation,” said Uplight CEO Adrian Tuck. “This investment and these partners help us scale the OS and the ecosystem better and faster, by increasing our scale and operations with energy providers, developing more deeply integrated solutions with other technology and energy solutions providers, both organically and through focused M&A, and catalyzing expansion into international markets.”
Uplight currently serves more than 80 energy providers, representing 110 million energy consumers, with the market’s widest array of sustainable digital solutions. Using data-driven insights to personalize and simplify the customer experience, Uplight solutions help utilities to reduce their baseload by changing consumer behavior, orchestrate grid connected devices that keep customers' bills low while adjusting in real time to changing grid conditions, and speed customer adoption of renewables, electric vehicles, and energy management solutions. The company posted an operating profit in 2020 with significant year-over-year ARR growth which continues in 2021. At the same time, Uplight's solutions delivered through its utility partners saved energy users more than an estimated $390 million on their energy bills while helping homes and businesses become more sustainable.
The investment group of global leaders is well aligned with Uplight, a certified B Corp, and its purpose of “creating a sustainable future using business as a force for good.” Huck Capital was formed to focus on transformational investments that bring together sustainability and growth in the energy sector. Coatue is an approximately $35 billion global technology fund that has invested over $5 billion in cleantech companies like SunRun, Tesla and Rivian. Inclusive Capital Partners, a global investment firm, partners with its investment companies to speed their environmental and social impact. Schneider Electric was recently named the world’s most sustainable corporation by research firm Corporate Knights and is the global leader in the digital transformation of energy management and automation, with distributed energy solutions for both commercial and utility scale. As a global leader in renewables and energy storage, AES partners with its customers to help them achieve their sustainable energy goals with a focus on offering innovative and integrated solutions while maintaining reliability.
Andres Gluski, AES President and Chief Executive Officer: “Uplight shares AES’ commitment to accelerate a smarter, greener energy future. Digital technologies engage customers in new ways for the more efficient use of energy. These tools improve customer satisfaction while reducing the carbon footprint of utility companies. We are continuing to invest in Uplight based on their proven track record and the great benefits these solutions bring for our customers and society.”
Steve McBee, CEO, Huck Capital: “Uplight sits at the center of two energy megatrends: the pivot to a zero-carbon economy and applying SaaS and data to connect and orchestrate behind-the-meter energy solutions. Software is the fuel driving the energy transition and Uplight is ideally positioned to win. We’re excited to work with the management team and the new investment partners to rapidly scale the business.”
Jean-Pascal Tricoire, Chairman and CEO, Schneider Electric: “Uplight’s software will enhance Schneider Electric’s existing EcoStruxure Grid offering and has further potential to play a key enabling role between Smart Grid, Smart Home and Smart Building. We look forward to investing alongside AES and the other financial investors, who all share our vision of a more digital and more electric world, leading to a sustainable future.”
Uplight delivers a unique and critical scale in the rapidly growing sustainable technology market by acting as the connective layer to create cohesive customer experiences at every step of the customer energy journey. Nomura Greentech Capital estimates the total potential market for sustainable energy technologies and related products at more than $900 billion globally, across thousands of products and solutions connected to energy consumers and the energy grid.
“Every energy solution provider participating in the new energy ecosystem is going to be better off partnering with us to connect their solutions to others and improve their value to customers. Uplight is making it easier and faster to deliver outcomes at scale and hit carbon reduction goals,” said Mr. Tuck.
The transaction is expected to close following the receipt of customary regulatory approvals. Goldman Sachs & Co. LLC served as Exclusive Advisor to Uplight; Nomura Greentech served as Advisor to the Investors.
About Uplight
Uplight is the technology partner for energy providers and the clean energy ecosystem. Uplight’s software solutions connect energy customers to the decarbonization goals of power providers while helping customers save energy and lower costs, creating a more sustainable future for all. Using the industry’s only comprehensive customer-centric technology suite and critical energy expertise across disciplines, Uplight is streamlining the complex transition to the clean energy ecosystem for more than 80 electric and gas utilities around the world. By empowering energy providers to achieve critical outcomes through data-driven customer experiences, delivering control at the grid edge, creating new revenue streams and optimizing existing load and assets, Uplight shares a mission with its clients to make energy more sustainable for every community. Uplight is a certified B Corporation. To learn more, visit us at www.uplight.com, find us on Twitter @Uplight or on LinkedIn at Linkedin.com/company/uplightenergy.
About AES
The AES Corporation (NYSE: AES) is a Fortune 500 global energy company accelerating the future of energy. Together with our many stakeholders, we're improving lives by delivering the greener, smarter energy solutions the world needs. Our diverse workforce is committed to continuous innovation and operational excellence, while partnering with our customers on their strategic energy transitions and continuing to meet their energy needs today. For more information, visit www.aes.com.
About Huck Capital
Huck Capital makes investments in a new generation of clean, customer facing energy companies that sustainably power the world's energy needs.
We are a team of former operators, investors and entrepreneurs who have deep industry experience transforming energy companies into more efficient and sustainable businesses. We believe that a net zero emissions future is possible through bold action to build resilient clean energy companies. www.huckcapital.com
About Schneider Electric
Schneider’s purpose is to empower all to make the most of our energy and resources, bridging progress and sustainability for all. We call this Life Is On. Our mission is to be your digital partner for Sustainability and Efficiency. We drive digital transformation by integrating world-leading process and energy technologies, end-point to cloud connecting products, controls, software and services, across the entire lifecycle, enabling integrated company management, for homes, buildings, data centers, infrastructure and industries. We are the most local of global companies. We are advocates of open standards and partnership ecosystems that are passionate about our shared Meaningful Purpose, Inclusive and Empowered values. www.se.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210302006221/en/
Contact information
Caleigh Bourgeois
kglobal
513-675-7466
caleigh.bourgeois@kglobal.com
Elaine Reddy
Uplight
720-252-8105
elaine.reddy@uplight.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Samsung Bioepis Announces Positive Preliminary Phase 1 and Phase 3 Data for SB27, a Proposed Biosimilar to Keytruda (Pembrolizumab)29.6.2026 10:19:00 EEST | Press release
Samsung Bioepis Co., Ltd. announced today that the Phase 1 and Phase 3 studies on SB27, a proposed biosimilar to Keytruda1 (pembrolizumab), have met their primary endpoints. “We are excited to announce preliminary results from the Phase 1 and Phase 3 studies for SB27, our pembrolizumab biosimilar candidate. These topline positive results reinforce our scientific expertise and leadership in biosimilar development,” said Donghoon Shin, Executive Vice President and Head of Clinical Sciences Division at Samsung Bioepis. “We are on track to complete both Phase 1 and Phase 3 studies within this year. Leveraging our robust quality management system, we remain committed to advancing our biosimilar portfolio to broaden access to life-saving biologic medicines for patients with unmet needs.” Pembrolizumab is a humanized monoclonal antibody that acts as an immune checkpoint inhibitor by targeting and blocking the programmed cell death protein 1 (PD-1) receptor on T cells. It is used to treat vari
IQM Named a Major Player in the IDC MarketScape: Worldwide Quantum Computing 2026 Vendor Assessment29.6.2026 10:00:00 EEST | Press release
IQM today announced it has been named a Major Player in the IDC MarketScape: Worldwide Quantum Computing 2026 Vendor Assessment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260629748732/en/ IQM named a major player in the IDC MarketScape IQM believes this recognition comes as institutions worldwide move quantum computing out of shared cloud access and into infrastructure they own and operate themselves. IQM calls this Production Quantum: full-stack, open-architecture superconducting systems deployed on premises, inside customers' own data centers and HPC environments, where organizations own the hardware, build internal expertise, and run quantum processors alongside their existing classical infrastructure. According to the IDC MarketScape, "For institutions building long-term quantum programs, this means the workflows and intellectual property developed on IQM hardware remain portable." The report further advises: "Consi
Zambon Announces Positive CHMP Opinion for Hopledo® (IPX203) for Adults with Parkinson’s Disease and Moderate to Severe Motor Fluctuations29.6.2026 10:00:00 EEST | Press release
Zambon today announced that the Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a marketing authorization by the European Medicines Agency (EMA) for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/DDC inhibitor-based treatment regimens. CHMP recommendation is based on data from the Phase 3 RISE-PD trial, which compared Hopledo® with immediate release levodopa/carbidopa (LD/CD) formulation in patients with Parkinson’s disease and moderate to severe motor fluctuations. In the study, Hopledo® demonstrated a significant increase in Good ON time over immediate release LD/CD with fewer daily doses and a comparable safety profile1. Hopledo® is a first-in-class, oral, modified-release formulation of LD/CD designed for the treatment of fluctuations of Parkinson’s diseas
Enhertu ® Approved in the EU as First Tumor Agnostic HER2 Directed Therapy and Antibody Drug Conjugate for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors29.6.2026 09:30:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been approved in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinion of the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on results from subgroups of patients with HER2 positive (IHC 3+) tumors across three phase 2 trials, including DESTINY-PanTumor02, DESTINY-Lung01 and DESTINY-CRC02. In DESTINY-PanTumor02, Enhertu demonstrated a confirmed objective response rate (ORR) of 52.3% (95% confidence interval [CI]: 42.6-6
Beerenberg Prevails in Patent Case Against Aspen Aerogels29.6.2026 08:00:00 EEST | Press release
The Korean Patent Court has invalidated three of Aspen Aerogels’ patents related to improved hydrophobic aerogel material. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260628192007/en/ Beerenberg delivers high-end insulation solutions built for performance, reliability, and long-term value. (Photo: Beerenberg) The ruling confirms the conclusion of the Intellectual Property Trial and Appeal Board (IPTAB) that the patents did not meet the necessary requirements for patentability. Beerenberg, which specializes in high-end insulation products, welcomes the court’s decision. “We are pleased that the case has now been concluded and that any uncertainty regarding the infringement claims has been removed,” says CEO Arild Apelthun. About Beerenberg Beerenberg has delivered cost-efficient solutions to a wide range of industrial enterprises for 49 years. The company is one of the leading suppliers of maintenance and modification serv
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
